🇺🇸

Index Intelligence

· daily

S&P 500 Consumer Staples Sector SEC Filings — May 13, 2026

Across 50 SEC filings primarily from Q1 2026 10-Qs, 8-Ks, and 13F-HRs (despite Consumer Staples focus, spanning diverse sectors with staples like Colgate-Palmolive, Coca-Cola Consolidated, Kroger, and Newell Brands), overarching themes include robust revenue growth in 12/18 reporting companies averaging +72% YoY (e.g., Momentus +899%, Motorsport +129%, Accelerant +53.5%) offset by widening net losses in 10/18 (avg +25% YoY deeper) due to op-ex inflation (+40% avg YoY). Staples sector showed governance stability with 100% proposal approvals at Colgate, Coca-Cola Cons, and Newell AGMs, alongside Kroger's strong 2025 recap (9% EPS growth, eCommerce profitable). Mixed sentiment dominated (14/50 filings), with positive AGMs (8/12) and neutral 13Fs (9/9 no changes). Forward guidance emerged bullish for Accelerant (FY EWP $5.2B+), ClearPoint ($52-56M rev), highlighting catalysts amid capex and M&A (e.g., Allegiant-Sun Country $140M synergies). Capital allocation leaned shareholder-friendly (buybacks at Accelerant, distributions +20% at New Mountain), but cash burns persisted in biotech/small caps. Portfolio-level: Margin expansion rare (ClearPoint +400bps to 64%), outliers in revenue surges signal growth pockets vs sector stagnation risks.

20 high priority 30 medium 50 total filings
· daily

S&P 500 Industrials Sector SEC Filings — May 13, 2026

Across 50 filings dominated by neutral 13F-HR disclosures from institutions like Third Avenue Management (heavy industrials exposure: Tidewater $77M, Valaris $50M, Boise Cascade $43M) and SouthernSun (Louisiana-Pacific $35M, Crane NXT $32M), portfolio snapshots reveal stable conviction in select S&P 500 Industrials amid tech-heavy allocations, with TRUSTCO BANK holding GE Aerospace ($6.7M). Operational 10-Q/8-K filings show mixed trends: revenue growth averaging +25% YoY in growth outliers like Shoulder Innovations (+65% to $16.7M Q1, guidance raised to $65-68M FY2026) and Pismo Coast Village (+13% to $2.2M), but sharp declines in biotechs like Aytu BioPharma (-33% Q3 revenue to $12.4M) and Semnur Pharma (opex +588% YoY). Banking peers reported robust net income gains (Finward +393% to $2.2M, Embassy +29% to $3.7M, Auburn +44% to $2.2M) driven by NII expansion (avg +13% YoY), though comprehensive losses from securities unrealized hits persist. Capital allocation highlights shareholder returns via NB Bancorp's completed 5% buyback (avg $20.96/share, cumulative 16% since 2025) and Embassy's $3M treasury repurchases. Forward catalysts include Shoulder FY guidance upgrade (37-44% growth), Inovio PDUFA Oct 30 2026, and XCF ops restart June 2026, signaling selective industrials/biotech alpha amid broader stability.

10 high priority 40 medium 50 total filings
· daily

S&P 500 Energy Sector SEC Filings — May 13, 2026

Across the 7 filings in the USA S&P 500 Energy intelligence stream, only Devon Energy provides direct sector exposure via its $475M stake in Waterbridge Infrastructure, signaling conviction in energy infrastructure amid neutral institutional 13F snapshots from managers favoring tech and industrials. Period-over-period trends in 10-Q filers reveal volatility: KAANAPALI LAND exploded with +4,529% YoY revenue to $20.4k from property sales, Winchester Bancorp posted +44% YoY net interest income and +11.4% assets, while Hughes Satellite saw -11.2% revenue but narrowed losses dramatically. Mixed sentiments dominate (3/4 applicable), with no insider trading activity disclosed, limited capital allocation (e.g., KAANAPALI's $981 distribution), and no forward-looking guidance except Hughes' going concern warning. Portfolio-level patterns show institutions maintaining diversified, tech-heavy positions with no major shifts QoQ/YOY. Key implication: Sparse direct energy insights, but Devon's outsized Waterbridge holding flags infrastructure opportunity; monitor non-energy filers for broader market spillovers into energy via capital flows. Overall, bullish turnarounds in KAANAPALI/Winchester contrast Hughes' distress, urging selective positioning.

3 high priority 4 medium 7 total filings
· daily

Dow Jones 30 Stocks SEC Filings — May 13, 2026

The 50 filings for USA Dow Jones 30 stream, dominated by 13F-HR disclosures from institutions managing trillions in AUM, reveal overwhelming conviction in DJIA mega-cap tech leaders like Apple (top holding in 20+ filings, e.g., First Citizens $153B, Visionary $101M), Amazon, Alphabet, Nvidia, and Microsoft, with select QoQ share increases (e.g., Alesco +5.4% AAPL, +2.3% AMZN). Operational 10-Q/8-K filings show mixed Q1 2026 results across non-DJIA names: robust growth in energy (NGS rental rev +21% YoY, EBITDA guide to $92.5-97.5M), airlines (ALGT Sun Country acquisition, $140M synergies), and tech (Cisco rev +12% YoY to $15.8B, FY guide $62.8-63B; Identiv +40.7% rev), but persistent cash burn and losses in biotechs (Acrivon op ex down 8% YoY but cash use +5%; Aquestive cash to $110M). Capital allocation trends favor returns: NGS div +36% to $0.15, NB Bancorp completed buybacks of 16% shares since IPO at $19.25 avg, Cisco $0.42 div. Forward guidance largely raised/reaffirmed (5/7 cases), signaling resilience amid margin pressures (e.g., Cisco gross margin -200bps to 63.6%). Portfolio-level patterns highlight tech overweight (60%+ top holdings), energy/mining adds (Kopernik +4.2% NovaGold), and fixed income ETF tilts for defense.

12 high priority 38 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — May 13, 2026

The 50 filings, dominated by 13F-HR reports from institutions managing trillions in AUM, reveal unwavering conviction in S&P 500 Consumer Discretionary mega-caps like Apple (e.g., First Citizens $153.7B position, Martingale $55.4M), Amazon ($62.6B First Citizens, $140M NewEdge), and Alphabet ($233M NewEdge Cl A), with stable Q1 2026 portfolios across 30+ filers signaling no major rotations out of consumer tech/retail leaders. Retail operators show sales headwinds (Fossil -3.6% YoY to $224.8M, Lulus -10% to $57.5M) but resilient margins (Fossil gross 59.9%, op margin 5.4% swing to profit) and cost discipline (Fossil SG&A -9.9%, Lulus inventory -17%), narrowing losses amid FY guidance for positive EBITDA (Lulus) and 3-5% adj margins (Fossil). Key catalysts include FedEx Freight spin-off (record May 15, trading June 1 2026, 80.1% dividend distribution unlocking $4.1B value) and Las Vegas Sands $1B debt refi (higher 5.3-5.65% rates vs 3.5%). Mixed financials/funds (e.g., Bogota NI -3.4% YoY, Finward +393%) hold consumer exposure, while crypto ETFs (Canary suite) post sharp NAV declines (XRP -18% QoQ, Solana -40.5%) on unrealized depreciation. No notable insider trades or buybacks; capital allocation leans to distributions (e.g., New Mountain $8.9M up YoY) and debt management. Portfolio-level trend: Steady institutional overweight in consumer discretionary amid ops challenges implies defensive positioning for H2 2026 recovery.

19 high priority 31 medium 50 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — May 13, 2026

Across 50 filings in the S&P 500 Healthcare intelligence stream dated May 13, 2026, direct operational updates from biotechs and providers reveal mixed Q1 2026 results with 7/9 healthcare firms showing narrowed net losses YoY (avg improvement ~40%) amid revenue ramps in select names like Precigen (+$21.9M YoY from near-zero on PAPZIMEOS launch) and Precision Optics (+108% YoY revenues), though cash burns persist and some revenues declined (e.g., CareView -2% YoY). 35+ 13F-HR filings from institutions like Merck, J&J, and others disclose stable holdings in healthcare/biotechs (e.g., Merck's $117M Moderna, J&J's $258M Protagonist), signaling sustained conviction without reported changes QoQ. Positive shareholder meetings at Vertex (97% avg director approval), Elevance Health, and others contrast proxy risks at Pacira; forward catalysts cluster in H2 2026 (PDUFAs, ASCO data). Capital allocation lean: dividends steady (e.g., Tri-County +12% YoY), no major buybacks noted in health filers. Portfolio-level trend: biotechs prioritizing commercialization (payer coverage expansions, J-codes) over R&D (avg -25% YoY spend), positioning for 2027 revenue inflection but risking near-term dilution.

19 high priority 31 medium 50 total filings
· daily

S&P 500 Technology Sector SEC Filings — May 12, 2026

Across 39 filings in the S&P 500 Technology stream (with some adjacent sectors), Q1 2026 results reveal robust revenue growth averaging +22% YoY in reporting companies (e.g., Ducommun +9%, Madison Air +33.8%, NVIDIA FY26 +65%), but mixed profitability with margin expansions in industrials (+70 bps Ducommun) offset by widening losses in biotechs (Immunome +29% YoY net loss). Institutional 13F-HR filings (13 total) show heavy concentration in tech/semiconductors (NVDA, AMD, Broadcom top holdings across Azimuth, Belvedere, Ilmarinen), signaling sustained conviction amid AI/data center tailwinds. Positive AGMs (Cadence 90-99% approvals, Atmus >95%) and capital raises (Madison IPO $2.58B net, AIM warrant exercise $3.6M) underscore shareholder alignment, while takeover tensions (Diana's 14.7% Genco stake, proxy fight June 18) add volatility. Forward guidance is optimistic where provided (Madison FY26 sales $3.75-3.85B, Immunome cash to 2028), but liquidity risks emerge in cash-burners (Imunon -45% QoQ cash). Sector themes highlight tech growth resilience vs. operational pressures in smaller names, positioning AI/semicon leaders for outperformance.

13 high priority 26 medium 39 total filings
· daily

Nasdaq 100 Stocks SEC Filings — May 12, 2026

Across 40 filings from NASDAQ-100 related entities on May 12, 2026, Q1 2026 earnings dominate with robust revenue growth in aerospace/defense (Ducommun +9% YoY), HVAC (Madison +33.8% YoY), IT services (Intellicheck +13% YoY, Intelligent Protection +15.2% YoY), and shipping (Genco EBITDA +331% YoY), but mixed profitability due to cost pressures and biotech losses widening (Immunome +29%, Imunon +3.6%). Margin expansions noted in 4/10 reporting companies (e.g., Ducommun gross +70 bps, Madison Adj EBITDA +89 bps), while cash positions declined QoQ in 7/12 cases amid inventory builds and R&D spends. Forward-looking catalysts include Madison FY2026 guidance ($3.75-3.85B sales), biotech trials (PepGen 2H 2026 data, Imunon Phase 3 2029), and AGMs (Genco/Dyadic June 18, NVIDIA June 24). Institutional 13Fs (Intel, AMD, Belvedere) show heavy tech/options exposure with no major shifts, signaling steady conviction. Shipping M&A battle (Diana 14.7% Genco stake, proxy fight) and capital raises (Madison IPO debt repay, AIM $3.6M warrants) highlight deleveraging trends. Portfolio implication: overweight aero/IT growth, monitor biotech liquidity and shipping takeover premium.

14 high priority 26 medium 40 total filings
· daily

S&P 500 Financials Sector SEC Filings — May 12, 2026

Across 50 filings in the USA S&P 500 Financials stream, 30+ are 13F-HR disclosures from asset managers and institutions revealing overwhelming concentration in mega-cap tech (Apple, NVIDIA, Amazon topping 80% of portfolios, avg 30-43% allocation) and ETFs, signaling strong conviction in tech amid financials focus. Earnings reporters (7 high-materiality 8-Ks) show mixed Q1 2026 trends: revenue growth averaging +11% YoY in 5/7 (Ducommun +9%, Qnity +18%, Green Dot +17%, Optex flat 6-mo, BETA +5.6%), but net losses widening in growth names (BETA to $122M from $78M) and GAAP declines (Qnity NI -19%). Guidance mostly raised (Qnity FY sales $5.225-5.375B +~10%, Optex FY rev $43-45M +5-9%), with margin expansions in industrials (Ducommun +70bps, Optex +390bps). Key developments include eBay rejecting $20B GameStop bid (confident in $80B GMV standalone), Green Dot B2B-driven +109% NI amid acquisition progress, and S&P Global Mobility spin-off Investor Day. Portfolio-level: Financial institutions underweight sector peers, overweight tech (e.g., National Pension $13B+ in top tech), implying rotation risks; capital allocation lean with News Corp $1B buyback and UGI €300M notes.

6 high priority 44 medium 50 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — May 12, 2026

The 50 filings for USA S&P 500 Consumer Staples stream reveal limited direct sector exposure, with institutional 13F-HR disclosures (22/50 filings) overwhelmingly concentrated in mega-cap tech (e.g., Apple, Nvidia, MSFT comprising 40-60% of portfolios across Circle Wealth, Channel Wealth, Sittner & Nelson, etc.), signaling broad investor preference for growth over defensive staples. Operational results from available Q1 2026 data show mixed trends: revenue growth in outliers like Qnity Electronics (+18% YoY to $1.3B, organic +17%) and New Mountain Net Lease (+11% YoY revenues), but declines in Under Armour (-1% Q4 YoY) and SideChannel (-16.8% Q2 YoY), with margin compression averaging -200-400 bps in pressured names amid cost inflation. Leadership changes dominate non-13F filings, with positive transitions (Diodes Chairman retirement after scaling revenue 10x, Standard Motor new COO) contrasting HF Sinclair's CEO/CFO separations (severance $4.7M, ongoing leave). Forward guidance includes Qnity's raised FY2026 sales ($5.225-5.375B, Adj EPS $3.80-4.14) and Under Armour's FY2027 slight revenue decline but +220-270 bps margins; annual meetings (Pangaea, Clearwater, Steele Bancorp) passed all items with strong majorities. Capital allocation leans conservative (e.g., no debt at Verde Clean Fuels with $54M cash), while M&A progress (Apellis HSR clearance for $41/share + CVR tender) and pipeline catalysts (Prelude Therapeutics IND mid-2026) offer spots of alpha. Overall, sparse staples-specific insights suggest sector stability via ETF holdings, but portfolio-level tilt to tech implies rotation risks if staples rally.

14 high priority 36 medium 50 total filings
· daily

S&P 500 Industrials Sector SEC Filings — May 12, 2026

The 50 filings for USA S&P 500 Industrials stream are dominated by 37 neutral 13F-HR disclosures from global managers (US, Hong Kong, Australia, Singapore), revealing Q1 2026 portfolios heavily concentrated in tech mega-caps (Apple, MSFT, NVDA topping 80% of filings, e.g., Circle Wealth 43% AAPL) and broad ETFs, signaling sustained institutional conviction in growth equities amid diversified risk via treasuries/quality factors. Operational filings (13 total) show mixed but resilient industrials trends: Ducommun (aerospace/defense) posted record Q1 revenue +9% YoY to $209M with gross margins +70bps to 26.9% and adj EBITDA +19%; Venture Global (LNG/infra) surged revenue +59% YoY to $4.6B, raising FY26 EBITDA guidance to $8.2-8.5B with new $8.6B project financing. Contrasts include sharp declines (VenHub revenue -86% YoY, Next Bridge -11% YoY with no reserves/employees) and ongoing losses (Verde Clean Fuels improved net loss to $2.4M YoY but cash burn persists; BCSF NII -8% QoQ, NAV -2.2%). Capital allocation leans supportive (BCSF $0.42 dividend covered, Venture $0.02/share, issuances for growth), with catalysts like S&P Global Mobility Investor Day (May 12, 2026) and leadership positives (Diodes new Chair). No insider transactions reported across filings; sector portfolio-level trends highlight aero/defense outperformance vs. energy explorers' weakness, positioning industrials for infra/LNG tailwinds but destocking risks.

7 high priority 43 medium 50 total filings
· daily

S&P 500 Energy Sector SEC Filings — May 12, 2026

Batch of 16 filings dominated by neutral 13F-HR disclosures from institutions (e.g., United Super $5.3B AUM, Stokes $969M, Chesapeake $126M) showing stable Q1 2026 holdings heavily skewed to tech mega-caps like NVDA ($327M top at United Super), AAPL, AMZN despite Energy sector focus, signaling broad market conviction in AI/big tech over pure energy plays. Energy sector highlights include SLB's $2B senior notes issuance at 4.55-5.15% (positive capital access for services/growth), Exxon's defensive DEFA14As rebutting proxy opposition to Texas redomicile (mixed governance risks), and Dorchester Minerals' annual meeting tomorrow with investor presentation. Operational trends mixed: Ampco-Pittsburgh Q1 sales +3.9% YoY to $108.3M and backlog to $345.5M on $124M orders but net loss $0.9M vs profit $1.1M YoY, Adj EBITDA margin -70bps to 7.4%; Orchestra BioMed revenue -87% YoY to $110k with loss widening 10%; XOMA income -23% YoY but net income +89% to $4.5k via gains; AOXY revenues +2% YoY. Cash flow improvements prominent (Ampco OCF +$7M YoY to +$1.7M, XOMA +178% to $6.1k, AOXY +37%). No insider trading activity noted across filings; capital allocation favors debt raises (SLB) and pension funding (Ampco fully funded). Portfolio-level: 10/14 new 13Fs neutral with sole discretionary holdings, no put/call shifts; implications point to energy tactical plays amid institutional tech stability.

4 high priority 12 medium 16 total filings
· daily

Dow Jones 30 Stocks SEC Filings — May 12, 2026

Across 50 SEC filings from Dow Jones 30-related streams, institutional 13F-HR reports (32/50) reveal overwhelming conviction in US tech giants (Apple, Microsoft, NVIDIA, Amazon topping nearly every portfolio, with aggregate values exceeding trillions), signaling bullish portfolio positioning amid ETF dominance for broad market exposure. Operational filings highlight robust LNG sector growth (Venture Global revenue +59% YoY to $4.6B, EBITDA guidance raised to $8.2-8.5B), accretive M&A (Global Net Lease acquiring Modiv for $535M, +4% AFFO accretive, Q3'26 close), and mixed small/mid-cap results (e.g., Optex revenue -10% YoY but margins +390 bps to 35.2%, FY guidance raised). Period trends show revenue growth in energy (avg +59% YoY) contrasting margin improvements in industrials/manufacturing (+390 bps) but declines in consumer/small caps (e.g., VenHub -86% YoY). Capital allocation favors dividends (Venture Global $0.02/share, Sound Financial +11% YoY to $0.21/share) and debt raises (Bain Capital $350M notes). Forward catalysts include Investor Days (S&P Global Mobility May 12, 2026), merger approvals (Volato/M2i), and court hearings (Honest Co. July 13, 2026), with neutral sentiment dominating 13Fs but positive M&A/earnings outliers driving actionable alpha in energy/REITs.

9 high priority 41 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — May 12, 2026

The May 12, 2026, filings for S&P 500 Consumer Discretionary reveal heavy institutional conviction via 40+ 13F-HRs, with Amazon.com as a top holding across 12 portfolios (e.g., 17.9%/$134M at GCQ Funds, $999M at Mitsubishi UFJ, $306M at United Super), alongside Uber (14%/$105M at GCQ) and exposure to eBay peers, signaling sustained allocation to e-commerce and ride-sharing amid neutral sentiment. Operational highlights include Aramark's robust Q2 FY2026 results (+15% YoY revenue to $4.9B, +12% organic, +40% adj EPS to $0.49, +116% FCF), eBay's rejection of GameStop's non-binding $20B debt-financed bid citing $80B 2025 GMV standalone strength, and mixed hospitality metrics like Ashford Hospitality's hotel sale improving pro forma net loss -4% YoY and SmartStop Self Storage's occupancy dip -70bps YoY to 92.3%. Period trends show growth divergence: 15-115% YoY revenue surges in services/infra (Aramark, JFB Construction, Cardinal Infrastructure) vs declines in volumes/occupancy (-11% rev at Next Bridge, rates down at SmartStop). Forward guidance is optimistic (e.g., Figure's Q2 vol $3.8-4.1B, Cardinal FY rev raised to $675-685M, Aramark leverage <3x FYE), with capital returns via Aramark's $25M buyback/$55M debt paydown/$0.12 dividend and Sound Financial's dividend hike to $0.21/share. Executive risks emerge (HF Sinclair CEO separation $4.7M severance, CFO leave), but no broad insider selling; overall, bullish flows favor selective e-comm/services overweight with hospitality watch.

12 high priority 38 medium 50 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — May 12, 2026

Across 50 filings dominated by Q1 2026 13F-HR disclosures, institutional investors maintain heavy overweight in mega-cap tech (AAPL top holding in 20+ managers, NVDA/LLY in select like Matthew 25's $25M LLY stake), signaling broad conviction amid limited S&P 500 Healthcare direct exposure beyond ETF proxies. Biotech filings (ProMIS, CalciMedica, Achieve, Sagimet, Unicycive, Harvard Bio, Pacira) reveal YoY net loss narrowing or swings to profit (e.g., Sagimet -41%, Achieve -20.6%, CalciMedica +$10M swing) driven by R&D cuts (-54% Sagimet, -17% CalciMedica), offset by $700M+ in fresh financings extending runways to 2027-2028. Revenue trends mixed: strong growth in sensors (VPG +17.6% YoY) vs declines in life sci tools (HBIO -4.7% YoY), with gross margins improving (HBIO +300bps to 59%). Forward catalysts cluster in H2 2026 (FDA feedbacks, trial readouts), while Pacira's proxy fight highlights activist risks. Non-health financials/REITs show deposit/asset growth (CB Financial +2.7% deposits QoQ) but expense pressures (New Mountain +27% YoY). Overall, actionable alpha in biotech pipelines undervalued vs sector, with institutional tech tilt implying healthcare laggard status.

11 high priority 39 medium 50 total filings
· daily

S&P 500 Technology Sector SEC Filings — May 11, 2026

Across 38 diverse SEC filings dominated by institutional 13F-HR disclosures, a clear portfolio-level pattern emerges of unwavering conviction in S&P 500 Technology mega-caps, with 12+ institutions reporting unchanged top holdings in Apple ($100M+ positions across NLB, MUFG EMEA, Elo, Nomura), Broadcom ($70M+ in NLB, $308M MUFG EMEA), Alphabet, Amazon, and Nvidia amid Q1 2026 portfolio stability. Period-over-period trends show mixed revenue performance outside tech: declines averaging -10% YoY in media (Townsquare -1.9%), semis (Sequans -29%), and logistics nine-month (Radiant -1.4%), offset by pockets of resilience like digital ad growth (+6.9% Townsquare) and hotel rev surges (+35% Portsmouth). Capital allocation favors dividends (Townsquare $0.20, Esquire $0.20 up from $0.175, Mueller $0.35), buybacks (Radiant $3.5M), while biotechs face cash burn (MoonLake -72% net loss YoY, runway to 2027). Forward-looking catalysts cluster in biotech (MoonLake BLA Sep 2026) and media guidance reaffirmations, but liquidation (Elme assets -72% QoQ) and going concern doubts (Planet Green) signal distress in non-core holdings. Implications: Bullish tech overweight via institutions supports sector rotation; selective opportunities in guided growth names amid broader small-cap weakness.

12 high priority 26 medium 38 total filings
· daily

Nasdaq 100 Stocks SEC Filings — May 11, 2026

Across 37 filings from NASDAQ-100 related entities on May 11, 2026, dominant themes include positive biotech catalysts (e.g., MoonLake, Intellia advancing BLAs), institutional stability with unchanged heavy tech allocations in 13Fs (Apple, Alphabet topping multiple portfolios), mixed quarterly results showing loss narrowing in small caps like Radiant Logistics (+88% net income YoY) and biotechs despite revenue dips, and ongoing liquidations/debt issuances signaling capital maneuvers. Period-over-period trends reveal 6/12 operational filings with YoY net loss improvements (avg +45% narrowing, e.g., Intellia -16%, Radiant +88%), but revenue stagnation/declines in logistics (Radiant flat) and semis/comms (Sequans -29%). Capital allocation leans toward buybacks (Radiant $3.5M), dividends (Mueller $0.35/share), and debt raises (Alphabet €9B, Booking €1.9B) for growth funding. Biotech forward-looking dominates with 4 BLA/PDUFA catalysts H2 2026-H1 2027, while Elme's liquidation eyes mid-2026 completion with $431M proceeds. Portfolio implications favor biotech alpha amid tech overweight stability, but flag cash burns and liquidation risks.

14 high priority 23 medium 37 total filings
· daily

S&P 500 Financials Sector SEC Filings — May 11, 2026

Across 50 SEC filings in the USA S&P 500 Financials stream dated May 11, 2026, mixed sentiment prevails in 25+ cases, with revenue growth averaging +20-30% YoY in high performers (e.g., NESR +33.5%, Gold.com +244%) offset by declines in 10+ firms (e.g., Townsquare -1.9%, Udemy -4%) and margin compressions (e.g., Dole EBITDA -4.3%). Financials-specific trends show banks expanding via M&A (Prosperity assets +13% QoQ to $43.6B, Western Alliance deposits +7.2%), BDCs with income gains but NAV pressure (Carlyle +16.8% investment income, -2.2% NAV), and 13Fs signaling conviction (MUFG $62B Morgan Stanley stake, Easterly Jackson Financial $22M). Capital allocation is robust with 12+ firms advancing dividends/buybacks (NESR new $0.10/share div + $50M repurchase, Prosperity $57M buybacks). Forward-looking data includes 5 guidance reaffirms/raises (Kodiak FY EBITDA $820-860M, Townsquare $420-440M rev) and catalysts like earnings calls on May 11. Portfolio-level patterns highlight M&A-driven growth in financial services, uneven Q1 profitability, and institutional flows into financial names amid volatility, favoring selective longs in capital-returning growers.

29 high priority 21 medium 50 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — May 11, 2026

Across 50 filings in the USA S&P 500 Consumer Staples intelligence stream (though spanning broader sectors like energy, biotech, and finance), mixed sentiment prevails with 12/20 high-materiality operational filings showing revenue growth (avg +35% YoY where positive, e.g., CleanCore +113%, Kodiak +6.2%) offset by widespread net losses or margin compression (e.g., HAIN -13% sales, OPAL -14% rev). Period-over-period trends reveal portfolio-level margin deterioration averaging -100bps in 6/10 reporting firms amid rising G&A (e.g., CleanCore +1350% YoY) and impairments, but capital allocation shines with debt reductions (ARKO -50% total debt QoQ, HAIN -$155M), buybacks/tenders (FS KKR $450M program), and reaffirmed/raised guidance (Kodiak EBITDA to $820-860M). Biotech and energy outliers like MoonLake/Intellia (BLA catalysts H2 2026) and Constellation (+1247% NI YoY) signal resilience, while 25+ 13F-HRs indicate steady institutional conviction in tech/ETFs (e.g., Apple, NVIDIA top holdings). Key implications: Favor debt deleveragers and guidance raisers for near-term alpha; monitor liquidation risks (Elme) and crypto volatility (CleanCore -$107M digital loss). Overarching theme: Defensive staples under pressure, but M&A/capex in adjacents (Calpine acquisition) drives upside.

11 high priority 39 medium 50 total filings
· daily

S&P 500 Industrials Sector SEC Filings — May 11, 2026

Across 50 SEC filings from S&P 500 Industrials and related sectors dated May 11, 2026, Q1 2026 earnings reveal mixed results with 8/12 reporting companies showing strong revenue growth averaging 32% YoY (e.g., Babcock & Wilcox +44%, Village Farms +27%) but widened net losses in 7/12 due to non-cash charges, merger costs, and expense inflation (avg net margin deterioration -300 bps). Restructuring themes dominate via spin-offs (Resideo's ADI Global at $4.8B rev), M&A proposals (Dream Finders for Beazer Homes), and leadership shuffles (Faraday Future, SolarEdge CFO), signaling value unlocks amid operational shifts. Defense/aerospace wins like Red Cat's $9.5M Army drone order contrast profitability pressures in hospitality (Target Hospitality EBITDA -54% YoY) and tech-adjacent (Udemy rev -4%). Capital returns remain robust with $200M+ aggregate buybacks/dividends in Q1 (e.g., Western Alliance $50M repurchases, Prosperity $57M). Institutional 13F filings (18/50) show steady mega-cap tech overweight (Apple, Alphabet top across portfolios) with minimal industrials shifts, implying defensive positioning. Forward catalysts cluster in H2 2026: spin-offs mid-Q3/Q4, investor days July, Phase 3 trials. Overall, tactical opportunities in contract wins and spin-offs outweigh broad margin risks, favoring selective longs in high-backlog names.

17 high priority 33 medium 50 total filings